ReShape Lifesciences Inc trading halted, news pending
PremiumThe FlyReShape Lifesciences Inc trading halted, news pending
2M ago
ReShape Lifesciences announces 1-for-58 reverse stock split
Premium
The Fly
ReShape Lifesciences announces 1-for-58 reverse stock split
2M ago
ReShape Lifesciences downgraded to Hold from Buy at Maxim
Premium
The Fly
ReShape Lifesciences downgraded to Hold from Buy at Maxim
4M ago
ReShape Lifesciences files to sell 11.7M shares of common stock for holders
PremiumThe FlyReShape Lifesciences files to sell 11.7M shares of common stock for holders
6M ago
ReShape Lifesciences receives notice of allowance for additional U.S. patent
Premium
The Fly
ReShape Lifesciences receives notice of allowance for additional U.S. patent
8M ago
RSLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RSLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago
Commercialization of 2.0 Flex to ramp up through 2024, ReShape CEO says
PremiumThe FlyCommercialization of 2.0 Flex to ramp up through 2024, ReShape CEO says
10M ago
GLP-1 drugs helping normalize obesity treatment, ReShape CEO tells The Fly
Premium
The Fly
GLP-1 drugs helping normalize obesity treatment, ReShape CEO tells The Fly
10M ago
ReShape CEO expects traction on partnership, merger discussions soon
Premium
The Fly
ReShape CEO expects traction on partnership, merger discussions soon
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100